CBT-I science

Coming off sleeping pills: what the research says about CBT-I

One trial tested exactly this: a supervised taper with and without CBT-I. The difference was large. What it found, who it was in, and why it starts with your prescriber.

October 7, 20264 min read

Last reviewed October 7, 2026

A line stepping down in five even stages, illustrating a gradual taper

If you are taking a sleeping pill and want to come off it, start with your prescriber - and know that there is good evidence CBT-I makes that process more likely to succeed. One randomized trial tested exactly this, and the difference between a supervised taper with CBT and a taper without it was large.

This article is about what the research shows. It is not instructions for changing a prescription, and nothing in it is a substitute for that conversation.

What the trial found

The trial enrolled older adults with chronic insomnia who were taking benzodiazepines, and compared three approaches: a supervised taper on its own, CBT on its own, and the two combined.

After treatment, the proportion who were medication-free was:

85% with supervised taper plus CBT;
48% with supervised taper alone;
54% with CBT alone.

The difference between groups was statistically significant (χ²=12.15, df=2, p=0.002).

Two things about that result matter. First, the combination clearly outperformed either approach alone. Second, it was a supervised taper - planned and monitored by clinicians - not people stopping on their own. The evidence is about that process, which is exactly why it starts with your prescriber.

It is also worth being precise about who was studied: older adults, taking benzodiazepines. Whether the same size of effect applies to other ages or other medications was not what this trial tested.

Why CBT-I helps

Medication works on the night it is taken. When it is reduced, whatever was keeping insomnia going is often still there - a weak sleep drive, a bed that has become a cue for wakefulness, worry about sleep - and sleep gets worse, which makes continuing the medication feel necessary.

CBT-I works on those underlying patterns. By the time medication is reduced, sleep is being held up by something other than the pill. How CBT-I works.

Take the free assessment to see:

✓Your Insomnia Severity Index (ISI) score
✓A personalized 6-week CBT-I plan, built by a sleep physician
✓How your sleep improves, night by night

Start free assessment

What the guidelines say about medication

Guidelines generally treat hypnotic medication as a short-term option. The American College of Physicians summary refers to use for no longer than four to five weeks. The European guideline defines short-term use as four weeks or less.

The American Academy of Sleep Medicine's guideline on insomnia medication makes fourteen drug recommendations, and every one is weak, on low or very low quality evidence. Its behavioral guideline, by contrast, strongly recommends CBT-I.

A 2026 AASM guideline on combination treatment suggests combining CBT-I with medication over medication alone - a conditional recommendation on low-certainty evidence. That is relevant if you want to start CBT-I while still taking something: you do not have to stop first. More on CBT-I and sleeping pills.

How to raise it with your prescriber

Many appointments about sleep end with a prescription renewed, because nobody brought anything else to the table. It helps to arrive with something specific:

that you want to reduce or come off the medication eventually;
that you are interested in CBT-I, and whether they can refer you or support a self-guided program alongside a taper;
what a supervised reduction would look like for your specific medication;
what to do if sleep worsens during it.

How to talk to your doctor about insomnia goes into this in more detail.

What not to do

Do not stop or change a sleep medication on your own, including cutting the dose. The evidence above is about supervised tapering, and the pace and method of any reduction depend on the medication, the dose, how long you have taken it and your health. That belongs with your prescriber.

If you are not sure CBT-I is right for you yet, what CBT-I is and how it compares with the other options are a good place to start, along with the rest of this section.

Somnera is a self-guided education program built on CBT-I, founded and written by Dr. Camilo Ruiz, DO, FACOI, FAASM. It is not a diagnosis and does not replace care from your own clinician. The assessment is free and takes about two minutes.

Citations

Morin CM, et al. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry. 2004;161(2):332–342. doi:10.1176/appi.ajp.161.2.332
Qaseem A, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–133. doi:10.7326/M15-2175
Riemann D, et al. The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023;32(6):e14035. doi:10.1111/jsr.14035
Sateia MJ, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307–349. doi:10.5664/jcsm.6470
Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255–262. doi:10.5664/jcsm.8986
Buysse DJ, et al. Combination treatment for chronic insomnia disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2026;22(1):56.

Frequently asked questions

In one randomized trial of older adults taking benzodiazepines for chronic insomnia, 85% of those who had a supervised taper combined with CBT were medication-free afterwards, against 48% with the taper alone. Any decision to reduce or stop medication should be made with your prescriber.

No, not on your own. You do not need to stop medication to start CBT-I. Any change to a prescription, including the pace of any reduction, is a decision for your prescriber.

Guidelines generally limit hypnotic medication to the short term. The American College of Physicians summary refers to no longer than four to five weeks, and the European guideline defines short-term as four weeks or less. Your prescriber can tell you what applies to your situation.

The trial evidence here is about supervised, gradual tapering. That is the approach to discuss with your prescriber, rather than stopping on your own.